Protagonist Therapeutics, Inc.
NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS

Last updated:

Abstract:

The invention relates to thioether monomer and dimer peptide molecules which inhibit binding of .alpha.4.beta.7 to the mucosal addressing cell adhesion molecule (MAdCAM) in vivo.

Status:
Application
Type:

Utility

Filling date:

29 Dec 2020

Issue date:

2 Dec 2021